Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Atrial Fibrillation Market Grown from 2024 to 2025?

Rapid expansion has been experienced in the size of the atrial fibrillation market in the past few years. The market size is projected to increase from $13.56 billion in 2024 to $15.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. The historic growth can be credited to factors such as heightened awareness and screening programs, technological advances in treatment, an upsurge in healthcare spending, clinical studies and drug development, and genetic susceptibility.

What Growth Rate Is Anticipated for the Atrial Fibrillation Market in the Coming Years?

The market size for atrial fibrillation is projected to experience a swift expansion in the forthcoming years, estimated to reach up to $24.93 billion by 2029 with a compound annual growth rate (CAGR) of 13.3%. The projected growth within this period can be ascribed to the increased emphasis on stroke prevention, educational activities about the condition for patients and doctors, worldwide initiatives for cardiovascular health, an upsurge in electrophysiology procedures, personalization of treatment plans, and government-led initiatives targeting prevention of cardiovascular disease. Factors trending within this forecast period that could greatly shape the expansion include improved diagnostic technologies, a surge in atrial fibrillation incidents, progress in catheter ablation methods, the development of novel oral anticoagulants (NOACs), the incorporation of wearable technology for patient monitoring, the enlarging scope of telemedicine in atrial fibrillation management, and continued progress in implantable devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Who Are the Leading Companies in the Atrial Fibrillation Market?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

What Are the Key Drivers of the Atrial Fibrillation Market?

The aging population is projected to propel the atrial fibrillation market. Senior citizens, aged 65 and above, are more prone to afflictions like postural hypotension and issues related to balance or gait, increasing their chances of falling. Most of these elderly patients display age-related and conduction disturbances on their surface electrocardiogram before the onset of atrial fibrillation. For example, the World Health Organization, a Switzerland-based United Nations agency specializing in international public health, reported in October 2022 that by 2030, the world’s elderly population (60 years and above) would reach six. By then, the number of this demographic will increase from 1 billion in 2020 to 1.4 billion. Furthermore, by 2050, the count of people aged 60 and above will practically double, reaching 2.1 billion. From 2020 to 2050, there will be an additional 426 million individuals aged 80 and above compared to the current count. Thus, the expanding elderly population is triggering the atrial fibrillation market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

What Are the Key Market Segments in the Atrial Fibrillation Industry?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

What Are the Latest Trends in the Atrial Fibrillation Market?

Leading businesses in the atrial fibrillation market, such as GE HealthCare, are introducing cutting-edge products and solutions, like patient-centric clinical decision support tools, to bolster their market presence. Clinical decision support tools (CDST) are essentially software or digital systems created to support healthcare practitioners in making timely and informed decisions regarding patient treatment. These tools amalgamate pertinent clinical information drawn from a variety of sources. A perfect example is from August 2023, when US-based multinational medical technology firm GE HealthCare unveiled CardioVisio. This patient-focused clinical decision support tool aids physicians in implementing evidence-based clinical decision support, following current atrial fibrillation protocols, and visualizing longitudinal data from various data sources crucial to illness progression. CardioVisio, specifically geared for atrial fibrillation, allows cardiologists to refine their image interpretation practices and provide a comprehensive overview of the patient’s heart condition along with their health progress, inclusive of past diagnoses, prescribed medication, interventions, and co-existing health conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

What Are the Key Regional Markets in the Atrial Fibrillation Industry?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

This Report Delivers Insight On:

1. How big is the atrial fibrillation market, and how is it changing globally?

2. Who are the major companies in the atrial fibrillation market, and how are they performing?

3. What are the key opportunities and risks in the atrial fibrillation market right now?

4. Which products or customer segments are growing the most in the atrial fibrillation market?

5. What factors are helping or slowing down the growth of the atrial fibrillation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model